PALV-08

• Research type

  Research Study

• Full title

  A Multicenter Open-Label Treatment Study Evaluating the Safety and Pharmacokinetics of PTX-022 in the Treatment of Adults with Pachyonychia Congenita

• IRAS ID

  1006674

• Contact name

  Pamela Swiggard

• Sponsor organisation

  Palvella Therapeutics, Inc.

• Eudract number

  2022-003182-38

• Clinicaltrials.gov Identifier

  NCT05643872

• Research summary

  Patients with Pachyonychia Congenita, a congenital hereditary disease with the leading characteristics of thickened finger and toe nails (onychauxis) and painful keratoma, will be treated with a new medication, PTX-022, wich is not yet on the market. All patients in this trial have already been treated with this medication in a prior trial.

• REC name

  London - South East Research Ethics Committee

• REC reference

  23/LO/0113

• Date of REC Opinion

  23 Mar 2023

• REC opinion

  Further Information Favourable Opinion